A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients with a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis - HELICON

Study identifier:ME-CV-1302

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients with a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis

Medical condition

Acute Coronary Syndrome

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

100000

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Aug 2013

Primary Completion Date: 01 Nov 2013

Study Completion Date: 01 Nov 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2014 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Linkoping, Sweden

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Contacts

Contact

Pernilla Aarskog

+46855323315

pernilla.aarskog@astrazeneca.com

Investigators

Principal Investigator

Magnus Janzon

Department of Cardiology, Linköping University Hospital, S-581 85 Linköping, Sweden